Skip to main content

Faculty Profile

basseres.jpgEugénie Bassères

Research Scientist
Department of Pharmacy Practice and Translational Research

Office: 
University of Houston College of Pharmacy
Health 2, Room 4045
4349 Martin Luther King Boulevard
Houston, TX 77204-5039

Contact: ebasseres@uh.edu - 832-842-8312

Research:

  • C.difficile pathogenesis
  • Microbiome models: bioreactors, gut-on chip
  • New antimicrobial mechanisms of action
  • Ph.D. (Biomedical Sciences) Karolinska Institute, Stockholm, Sweden
  • M.S. (Infectious Diseases and Tropical Pathologies) University of Aix-Marseille, France
  • B.S. (Biochemistry) University of Montpellier, France

Google Scholar Profile
  • M Engevik, H Danhof, J Auchtung, BT Endres, W Ruan, E Bassères, Q Wu, M Nicholson, RA Luna, KW Garey, SE Crawford, MK Estes, R Lux, MB Yacyshyn, B Yacyshyn, T Savidge, R Britton, J Versalovic. Fusobacterium nucleatum adheres to Clostridioides difficile via the RadD adhesin to enhance biofilm formation in intestinal mucus. Gastroenterol 2021Mar;160(4):13011314.e8.doi:10.1053/j.gastro.2020.11.034. 
  • Bassères E, Endres BT, Montes-Bravo N, Pérez-Soto N, Rashid T, Lancaster C, Begum K, Alam MJ, Paredes-Sabja D, Garey KW. Visualization of fidaxomicin association with the exosporium layer of Clostridioides difficile spores. Anaerobe. 2021 Feb 25;69:102352. doi:10.1016/j.anaerobe.2021.102352. 
  • Bassères E, Begum K, Lancaster C, Gonzales-Luna AJ, Carlson TJ, Miranda J, Rashid T, Alam MJ, Eyre DW, Wilcox MH, Garey KW. In vitro activity of eravacyclin against common ribotypes of C. difficile. J Antimicrob Chemother. 2020 Oct 1;75(10):2879-2884.
  • Begum K, Bassères E, Miranda J, Lancaster C, Gonzales-Luna AJ, Carlson TJ, Rashid T, Eyre DW, Wilcox MH, Alam MJ, Garey KW. In vitro activity of Omadacycline, a new tetracycline analog, and comparators against C. difficile. J Antimicrob Chemother. 2020 Jul 22;64(8):e00522-20.
  • Bassères E*, Endres BT*, Khaleduzzaman M, Miraftabi F, Alam MJ, Vickers RJ, Garey KW. Impact on toxin production and cell morphology in C. difficile by ridinilazole (SMT19969), a novel treatment for C. diificile infection. J Antimicrob Chemother. 2016 May;71(5):1245-51.

Awards & Honors

  • 50 in 5 scholar of year 2021 (top 50 UH faculty members who authored high-impact journal articles)